12 results
PRE 14A
NTLA
Intellia Therapeutics Inc
18 Apr 23
Preliminary proxy
4:16pm
business strategy team. Dr. Verwiel was also managing director of Merck’s Dutch subsidiary from June 1996 to May 2001. Prior to his tenure at Merck, he had … technology activities and played a critical strategic role in AbbVie’s licensing and acquisition activities. Prior to his tenure at AbbVie, he served
8-K
EX-99.1
NTLA
Intellia Therapeutics Inc
17 Apr 23
Intellia Therapeutics Names Bill Chase to its Board of Directors
4:59pm
on to serve as executive vice president, Finance and Administration from October 2018 to July 2019.
Prior to his tenure at AbbVie, Mr. Chase spent
8-K
0kdszaqzg2ci 1npi
17 Apr 23
Intellia Therapeutics Names Bill Chase to its Board of Directors
4:59pm
8-K
1z9q6i x7p
3 May 22
Departure of Directors or Certain Officers
7:00am
- Prev
- 1
- Next